Preclinical peptide research relies heavily on animal models (mice, rats, dogs, primates) to study bioactivity and mechanism of action. However, significant species differences in anatomy, physiology, pharmacology, and gene expression exist, so a result obtained in one species cannot be assumed to hold in another (McGonigle & Ruggeri, 2014). Understanding species-specific variations in peptide receptor expression, signaling pathways, and tissue responses is essential for choosing an appropriate model and interpreting results within the limits of that model.
Receptor Expression and Signaling Divergence Across Species
Peptide receptors can show different expression levels, tissue distribution, and pharmacology across species. Receptor subtypes that are prominent in one species may be scarce in another, and small sequence differences in a receptor can change how it binds a ligand. The neurokinin-1 (NK-1) receptor is a classic example: several nonpeptide antagonists bound the human NK-1 receptor with 15- to 76-fold higher affinity than the rat receptor, even though such receptor differences are often neutral for the natural peptide ligand; the selectivity was traced to a few divergent residues in the receptor (Jensen et al., 1994). Differences of this kind affect potency comparisons and concentration–response relationships between models. When a peptide’s activity has been reported in several rodent models, researchers still regard each species as a separate system and check receptor sequence and expression before comparing results.
Anatomical and Physiological Differences Affecting Peptide Outcomes
Species differences in anatomy and physiology influence wound healing kinetics, immune responses, and tissue repair timing.
Wound healing. Rodent skin is loose and has a panniculus carnosus muscle layer, so excisional wounds close largely by contraction rather than by re-epithelialization and granulation tissue. Splinting the wound with a silicone ring reduces contraction and makes healing occur mainly through re-epithelialization (Galiano et al., 2004). Pig skin is closer in structure to human skin and is often used as a comparison model (Sullivan et al., 2001).
Immunology. Mice and humans differ in the balance of leukocyte subsets, Toll-like receptor expression, cytokine and chemokine biology, and other components of innate and adaptive immunity (Mestas & Hughes, 2004).
Digestive physiology and microbiota. Rodents differ in gastrointestinal transit time, stomach pH, and gut microbiota composition, and the microbiota of laboratory animals varies between vendors and facilities, which can affect reproducibility (Hugenholtz & de Vos, 2018).
Cardiovascular anatomy. Heart size, heart rate, and coronary anatomy differ substantially between rodents and larger mammals. These physiological differences can lead to different tissue responses to the same peptide, which is why researchers often confirm key findings in a second model, including three-dimensional tissue cultures and organoids.
The Mouse Model Debate
How well do mouse models capture complex responses? An analysis of genomic responses to trauma, burns, and endotoxemia concluded that responses in mouse models correlated poorly with those in humans (Seok et al., 2013). A reanalysis of the same datasets using a different method concluded that the mouse responses mimicked the human ones much more closely (Takao & Miyakawa, 2015). The exchange shows that conclusions about model fidelity depend heavily on analytic choices, and that the relevance of a model should be judged question by question.
Designing Peptide Studies That Account for Species
Check receptor homology. Compare receptor sequences and, where possible, measure binding or potency at the receptor of the species being studied.
Use species-matched reagents. Antibodies, ELISA kits, and recombinant proteins should match the model species.
Measure stability in the right matrix. Peptidase activity in serum or plasma differs between species, so stability assays should use plasma from the model species. Our peptide stability article discusses matrix effects.
Report the model fully. The ARRIVE 2.0 guidelines list the information needed to evaluate animal studies, including species, strain, sex, age, housing, and randomization (Percie du Sert et al., 2020).
Pick the model for the question. A splinted mouse wound, a pig skin model, or a human-cell organoid each answer different questions; none is universally best.
For compound-specific background, see our BPC-157 research guide and our overview of research ethics and the 3Rs.
Key Findings from the Literature
Small receptor differences can change pharmacology. Nonpeptide antagonists bound the human NK-1 receptor 15- to 76-fold more tightly than the rat receptor (Jensen et al., 1994).
Wound models need design choices. Splinting changes how mouse wounds close (Galiano et al., 2004).
Mouse and human immunity differ. Differences span innate and adaptive components (Mestas & Hughes, 2004).
Model fidelity is debated. The same genomic datasets supported opposite conclusions under different analyses (Seok et al., 2013; Takao & Miyakawa, 2015).
Frequently Asked Questions
Why do results differ between mice and rats?
They differ in receptor sequences, metabolism, immune function, and peptidase activity, so a peptide can show different potency or stability in each.
Why are pig skin models used in wound research?
Pig skin is closer in structure to human skin than rodent skin is, and wounds heal less by contraction (Sullivan et al., 2001).
What are the ARRIVE guidelines?
A checklist for reporting animal research so that others can evaluate and reproduce it, covering design, sample size, randomization, blinding, and the animals used.
Can BioSim peptides be used in people?
No. BioSim peptides are supplied for laboratory research use only and are not for human or veterinary use.
All BioSim peptides are supplied for laboratory research use only. They are not for human or veterinary use.
References
Galiano RD, Michaels J 5th, Dobryansky M, et al. (2004). Quantitative and reproducible murine model of excisional wound healing. Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society, 12(4), 485-92. PMID: 15260814 · DOI: 10.1111/j.1067-1927.2004.12404.x
Hugenholtz F, de Vos WM (2018). Mouse models for human intestinal microbiota research: a critical evaluation. Cellular and molecular life sciences : CMLS, 75(1), 149-160. PMID: 29124307 · DOI: 10.1007/s00018-017-2693-8
Jensen CJ, Gerard NP, Schwartz TW, et al. (1994). The species selectivity of chemically distinct tachykinin nonpeptide antagonists is dependent on common divergent residues of the rat and human neurokinin-1 receptors. Molecular pharmacology, 45(2), 294-9. PMID: 7509441
McGonigle P, Ruggeri B (2014). Animal models of human disease: challenges in enabling translation. Biochemical pharmacology, 87(1), 162-71. PMID: 23954708 · DOI: 10.1016/j.bcp.2013.08.006
Mestas J, Hughes CC (2004). Of mice and not men: differences between mouse and human immunology. Journal of immunology (Baltimore, Md. : 1950), 172(5), 2731-8. PMID: 14978070 · DOI: 10.4049/jimmunol.172.5.2731
Percie du Sert N, Hurst V, Ahluwalia A, et al. (2020). The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research. PLoS biology, 18(7), e3000410. PMID: 32663219 · DOI: 10.1371/journal.pbio.3000410
Seok J, Warren HS, Cuenca AG, et al. (2013). Genomic responses in mouse models poorly mimic human inflammatory diseases. Proceedings of the National Academy of Sciences of the United States of America, 110(9), 3507-12. PMID: 23401516 · DOI: 10.1073/pnas.1222878110
Sullivan TP, Eaglstein WH, Davis SC, et al. (2001). The pig as a model for human wound healing. Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society, 9(2), 66-76. PMID: 11350644 · DOI: 10.1046/j.1524-475x.2001.00066.x
Takao K, Miyakawa T (2015). Genomic responses in mouse models greatly mimic human inflammatory diseases. Proceedings of the National Academy of Sciences of the United States of America, 112(4), 1167-72. PMID: 25092317 · DOI: 10.1073/pnas.1401965111
Related Products: Products discussed in this article: BPC-157 10mg. Our research peptides are 99%+ purity and third-party tested; available certificates of analysis are published on our COA page. For laboratory research use only.
Related Research: Research Ethics and Regulatory Compliance in Peptide Studies: Ensuring Responsible Science | BPC-157 Research Guide: Mechanisms & Preclinical Data
